TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Tarpoon Bioscience AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
618
|
565
|
915 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
551
|
345
|
168 |
| EBITDA |
534
|
324
|
160 |
| Total assets |
2,526
|
2,216
|
2,105 |
| Current assets |
583
|
752
|
649 |
| Current liabilities |
109
|
64
|
159 |
| Equity capital |
2,285
|
2,039
|
1,850 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
90.5%
|
92.0%
|
87.9% |
| Turnover per employee |
618
|
565
|
915 |
| Profit as a percentage of turnover |
89.2%
|
61.1%
|
18.4% |
| Return on assets (ROA) |
21.9%
|
15.6%
|
8.0% |
| Current ratio |
534.9%
|
1175.0%
|
408.2% |
| Return on equity (ROE) |
24.1%
|
16.9%
|
9.1% |
| Change turnover |
71
|
-355
|
-8 |
| Change turnover % |
13%
|
-39%
|
-1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.